Novel Turmeric Extract Improves Cognition; Carotenoids Linked to Paediatric Health

Singapore, Singapore — 07 August 2026

New scientific findings offer supplement brand owners actionable intelligence across key health categories, including cognitive function, paediatric health, and mood support. A proprietary dual-extracted Curcuma longa ingredient, focusing on active sesquiterpenoids rather than curcuminoids, demonstrated significant improvements in orientation and attention scores. Conducted by researchers at House Wellness Foods Corp. and published in Frontiers in Nutrition, the 24-week randomised controlled trial (RCT) involved healthy participants with mild cognitive weaknesses, indicating a strong data basis for new product development targeting the rapidly expanding cognitive health market.

Separately, a comprehensive review published in Nutrients, analysing studies up to January 2026, highlighted the potential of carotenoid supplementation for vision and cognitive benefits in children. The review noted early life exposure to carotenoids from maternal serum and human milk correlates with cognitive function, suggesting these compounds are primary concentrated elements in developing brain tissues. While promising, the review advises further long-term studies are required to fully substantiate carotenoids' efficacy as an adjunctive therapy for paediatric health, creating an R&D focus area for ingredient suppliers.

Further research from China, South Korea, and the USA, published in Frontiers in Nutrition, showcased the superior performance of precision synbiotics over probiotics alone for toddler gut-immune health. This multi-centre 12-week trial involving 390 toddlers found that combining the human milk oligosaccharide (HMO) 2’-FL with specific Bifidobacterium strains significantly reduced infectious and atopic disease risk, pointing to a robust platform for next-generation early childhood nutrition products. This offers a clear market differentiator for brands capable of delivering complex synbiotic formulations.

Elsewhere, daily supplementation with Pediococcus acidilactici PA53 for eight weeks improved gastrointestinal health, sleep quality, and happiness scores in older adults, alongside a 9.5% reduction in GI symptoms and a 28% improvement in stool consistency. This probiotic, detailed in The Journal of Nutrition, also decreased inflammatory markers IL-6 and TNF-alpha, positioning it as a multi-benefit ingredient for the aging consumer demographic. Additionally, a 24-week RCT, detailed in Obesity Pillars, indicated a hop-derived nutraceutical (Calocurb – proprietary bitter hop extract Amarasate) aided adults with overweight in losing body fat while maintaining muscle mass, opening avenues for weight management product innovation beyond appetite suppression.

What this means for Singapore

Singaporean brand owners should prioritise ingredient sourcing for these newly validated compounds. The specific cognitive benefits of House Wellness Foods' turmeric extract present a first-mover advantage in a competitive market; reformulations should target older demographics seeking validated brain support. For the paediatric sector, while carotenoids show promise, local regulatory bodies like the Health Sciences Authority (HSA) will require robust clinical substantiation for 'adjunctive therapy' claims, necessitating collaborative R&D. The synbiotic findings offer a clear product development pathway for toddler formulations, allowing brands to command premium pricing through superior efficacy. Manufacturers must also assess supplier readiness for ingredients like Pediococcus acidilactici PA53 and hop extracts to meet growing demand for mood, gut, and weight management solutions without compromising supply chain stability.

Many leading brands in this category are manufactured in partnership with Supplement Factory.